Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer - Van Cutsem, Eric; Collignon, Joëlle; Eefsen, Rikke L; Ochsenreither, Sebastian; Zvirbule, Zanete; Ivanauskas, Audrius; Arnold, Dirk; Baltruskeviciene, Edita; Pfeiffer, Per; Yachnin, Jeffrey; Magnusson, Susanne; Rydberg Millrud, Camilla; et al. (Clinical Cancer Research, 2024)